Pharma Journalist -

CytoDyn Inc. a late-stage biotechnology company developing Vyrologix™ (leronlimab-PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced it…
Read More...

Prestige BioPharma Limited (PBP) and Busan City Government announced that the two organisations have entered into a memorandum of understanding (MOU) for the establishment of Research…
Read More...

BioMed X announced the extension of its ongoing collaboration with Merck. Under the new agreement, Merck will start up to six additional research projects at the BioMed X Institute,…
Read More...

InnoCare a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced that China National Medical Products Administration has approved the Phase I clinical…
Read More...

SMi Reports: Registration is open for SMi Group’s 2nd annual Wearable Injectors and Connected Devices Conference taking place 18th -19th October in London. This Conference will explore…
Read More...

PerkinElmer, Inc. and Immunodiagnostic Systems Holdings PLC are pleased to announce that they have reached an agreement on the terms of a recommended all cash offer whereby PerkinElmer…
Read More...

Charles River Laboratories International, Inc. announced that it has signed a definitive agreement to acquire Vigene Biosciences, Inc., a premier, U.S.-based gene therapy contract…
Read More...

AffyImmune Therapeutics, Inc., a clinical stage biotechnology company finding safe, effective ways to use CAR T cells against solid cancers, announced that the US Food and Drug…
Read More...

Lennham Pharmaceuticals, a clinical-stage start-up focused on the creative use of deuterium chemistry to improve the metabolic and pharmacological profile of existing compounds,…
Read More...

In Q4 2020 CordenPharma announced both an expansion of non-GMP capacity at our Centre of Excellence for Peptide Process Development in Frankfurt, Germany, and a major increase in…
Read More...